XJPX9273
Market cap161mUSD
Jan 17, Last price
600.00JPY
1D
0.00%
1Q
-3.54%
IPO
97.53%
Name
Koa Shoji Holdings Co Ltd
Chart & Performance
P/E
8.58
P/S
1.14
EPS
69.95
Div Yield, %
1.88%
Shrs. gr., 5y
0.06%
Rev. gr., 5y
7.80%
Revenues
22.13b
+0.37%
Net income
2.95b
+9.64%
CFO
3.83b
+39.96%
Dividend
Jun 27, 20250 JPY/sh
Profile
Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells APIs/intermediates in Japan. It is also involved in the manufacture and marketing of various injections; OTC drugs, primarily various vitamins; and manufacture and sale of generic drugs. In addition, the company engages in contract manufacturing of pharmaceuticals; and packaging of pharmaceutical products. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
| Income | |||||||||
Revenues | 22,134,145 0.37% | 22,052,802 8.35% | 20,353,415 14.24% | ||||||
Cost of revenue | 17,883,543 | 17,913,967 | 16,628,316 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 4,250,602 | 4,138,835 | 3,725,099 | ||||||
NOPBT Margin | 19.20% | 18.77% | 18.30% | ||||||
Operating Taxes | 1,421,718 | 1,404,645 | 1,394,277 | ||||||
Tax Rate | 33.45% | 33.94% | 37.43% | ||||||
NOPAT | 2,828,884 | 2,734,190 | 2,330,822 | ||||||
Net income | 2,946,337 9.64% | 2,687,220 13.90% | 2,359,319 10.41% | ||||||
Dividends | (475,382) | (436,213) | (395,443) | ||||||
Dividend yield | 1.71% | 1.60% | 1.39% | ||||||
Proceeds from repurchase of equity | 1,627,298 | (31) | |||||||
BB yield | -5.84% | 0.00% | |||||||
| Debt | |||||||||
Debt current | 1,233,904 | 1,199,904 | 1,199,904 | ||||||
Long-term debt | 1,591,384 | 1,958,048 | 2,333,716 | ||||||
Deferred revenue | 273,221 | 244,927 | |||||||
Other long-term liabilities | 382,877 | 91,123 | 103,669 | ||||||
Net debt | (11,230,672) | (7,711,064) | (5,699,750) | ||||||
| Cash flow | |||||||||
Cash from operating activities | 3,830,664 | 2,736,953 | 2,094,186 | ||||||
CAPEX | (1,439,000) | (271,000) | (443,000) | ||||||
Cash from investing activities | (1,471,124) | (304,113) | (477,331) | ||||||
Cash from financing activities | 795,246 | (812,059) | (804,934) | ||||||
FCF | 1,489,063 | 2,516,496 | 1,619,027 | ||||||
| Balance | |||||||||
Cash | 13,954,886 | 10,767,016 | 9,123,370 | ||||||
Long term investments | 101,074 | 102,000 | 110,000 | ||||||
Excess cash | 12,949,253 | 9,766,376 | 8,215,699 | ||||||
Stockholders' equity | 24,029,778 | 20,718,066 | 18,460,409 | ||||||
Invested Capital | 15,310,589 | 13,852,636 | 13,480,419 | ||||||
ROIC | 19.40% | 20.01% | 17.77% | ||||||
ROCE | 15.04% | 17.52% | 17.16% | ||||||
| EV | |||||||||
Common stock shares outstanding | 39,742 | 39,619 | 39,619 | ||||||
Price | 701.00 1.59% | 690.00 -3.90% | 718.00 5.12% | ||||||
Market cap | 27,859,054 1.91% | 27,336,851 -3.90% | 28,446,196 5.12% | ||||||
EV | 16,628,382 | 19,625,787 | 22,746,446 | ||||||
EBITDA | 4,976,653 | 4,831,428 | 4,403,341 | ||||||
EV/EBITDA | 3.34 | 4.06 | 5.17 | ||||||
Interest | 7,533 | 7,462 | 11,077 | ||||||
Interest/NOPBT | 0.18% | 0.18% | 0.30% | ||||||